Ribozyme-mediated suppression of platelet type 12 lipoxygenase in human erythroleukemia cells

Cancer Gene Therapy

Volumn 7, Issue 5, 2000, Pages 671-675

  Liu, Canhui ^a   Sun, Lun Quan ^b,c   Tien, Po ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b JOHNSON AND JOHNSON   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Angiogenesis; Human erythroleukemia cells; Platelet type 12 lipoxygenase; Ribozyme

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; LIPOXYGENASE; MESSENGER RNA; RIBOZYME;

ANGIOGENESIS; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; BREAST CANCER; ENDOTHELIUM CELL; ENZYME ACTIVITY; ERYTHROLEUKEMIA CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

MAMMALIA;

EID: 0034022252     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700149     Document Type: Article

References (23)

1. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1999;86:353-364.
2. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267: 353-364.
3. Gao X, Grignon DJ, Chbihi T, et al. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology. 1995;46:227-237.
4. Connolly JM, Rose DP. Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected MCF-7 human breast cancer cells in athymic nude mice. Cancer Lett. 1998;132:107-112.
5. Nie D, Hillman GG, Geddes T, et al. Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Cancer Res. 1998;58:4047-4051.
6. Haseloff J, Gerlach WL. Simple enzymes with new and highly specific endoribonuclease activity. Nature. 1988; 334:585-591.
7. Hampel A, Tritz R. RNA catalytic properties of the minimum (-)sTRSV sequence. Biochemistry. 1989;28:4929-4933.
8. Rossi JJ. Ribozymes. Curr Opin Biotechnol. 1992;3:3-7.
9. Sarver N, Cantin EM, Chang PS, et al. Ribozymes as potential anti-HIV-1 therapeutic agents. Science. 1990; 247:1222-1225.
10. Sun LQ, Warrilow D, Wang L, Witherington C, Macpherson J, Symonds G. Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type 1 replication in permissive cell lines. Proc Natl Acad Sci USA. 1994;91:9715-9719.
11. Yu M, Ojwang J, Yamada O, et al. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 1993;90: 6340-6344.
12. Welch PJ, Tritz R, Yei S, Barber J, Yu M. Intracellular application of hairpin ribozyme genes against hepatitis B virus. Gene Ther. 1997;4:736-743.
13. Welch PJ, Tritz R, Yei S, Leavitt M, Yu M, Barber J. A potential therapeutic application of hairpin ribozymes: in vitro and in vivo studies of gene therapy for hepatitis C virus infection. Gene Ther. 1996;3:994-1001.
14. Scanlon KJ, Jiao L, Funato T, et al. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc Natl Acad Sci USA. 1991;88:10591-10595.
15. Scanlon KJ, Ishida H, Kashani-Sabet M. Ribozyme-mediated reversal of the multidrug-resistant phenotype. Proc Natl Acad Sci USA. 1994;91:11123-11127.
16. Yang XC, Yie Y, Zhu F, et al. Ribozyme-mediated high resistance against potato spindle tuber viroid in transgenic potatoes. Proc Natl Acad Sci USA. 1997;94:4861-4865.
17. Tabilio A, Rosa JP, Testa U, et al. Expression of platelet membrane glycoproteins and α-granule proteins by a human erythroleukemia cell line (HEL). EMBO J. 1984;3:453-459.
18. Sun LQ, Ely JA, Gerlach WL, Symonds G. Anti-HIV ribozymes. Mol Biotechnol. 1997;7:241-251.
19. Funk CD, Furci L, FitzGerald GA. Molecular cloning, primary structure, and expression of the human platelet/ erythroleukemia cell 12-lipoxygenase. Proc Natl Acad Sci USA. 1990;87:5638-5642.
20. Sun LQ, Wang L, Gerlach WL, Symonds G. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA. Nucleic Acids Res. 1995;23:2909-2913.
21. Gu JL, Veerapanane D, Rossi J, Natarajan R, Thomas L, Nadler J. Ribozyme-mediated inhibition of expression of leukocyte-type 12-lipoxygenase in porcine aortic vascular smooth muscle cells. Circ Res. 1995;77:14-20.
22. Wang L, Witherington C, King A, et al. Preclinical characterization of an anti-tat ribozyme for therapeutic application. Hum Gene Ther. 1998;9:1283-1291.
23. + peripheral blood lymphocytes in HIV discordant identical twins. Hum Gene Ther. 1999;10:1402-1421.